Share

Pfizer vaccine shows efficacy in South Africa

A new Pfizer vaccine study shows 91 percent efficacy after six months. The company also released early data which suggests efficacy against the South African variant. CNBC's Meg Tirrell reports.
03:59
Thu, Apr 1 20217:03 AM EDT